achondroplasia

The European Commission (EC) has approved BioMarin Pharmaceutical Inc's (NASDAQ: BMRN) Voxzogo (vosoritide) once-daily injection to treat achondroplasia. The approval covers children from 2 years until growth plates are closed, which occurs after puberty when children reach...